Elevation Oncology Inc (ELEV)
4.02
-0.05
(-1.23%)
USD |
NASDAQ |
May 31, 16:00
4.04
+0.02
(+0.50%)
After-Hours: 20:00
Elevation Oncology Enterprise Value: 146.40M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 146.40M |
| May 30, 2024 | 149.14M |
| May 29, 2024 | 143.67M |
| May 28, 2024 | 136.02M |
| May 24, 2024 | 136.57M |
| May 23, 2024 | 128.37M |
| May 22, 2024 | 134.93M |
| May 21, 2024 | 130.56M |
| May 20, 2024 | 131.11M |
| May 17, 2024 | 124.00M |
| May 16, 2024 | 124.00M |
| May 15, 2024 | 130.56M |
| May 14, 2024 | 121.27M |
| May 13, 2024 | 120.18M |
| May 10, 2024 | 105.97M |
| May 09, 2024 | 118.54M |
| May 08, 2024 | 122.36M |
| May 07, 2024 | 116.90M |
| May 06, 2024 | 131.11M |
| May 03, 2024 | 128.92M |
| May 02, 2024 | 135.48M |
| May 01, 2024 | 145.31M |
| April 30, 2024 | 120.72M |
| April 29, 2024 | 137.12M |
| April 26, 2024 | 124.55M |
| Date | Value |
|---|---|
| April 25, 2024 | 125.91M |
| April 24, 2024 | 138.75M |
| April 23, 2024 | 162.80M |
| April 22, 2024 | 148.04M |
| April 19, 2024 | 134.38M |
| April 18, 2024 | 145.86M |
| April 17, 2024 | 152.96M |
| April 16, 2024 | 166.62M |
| April 15, 2024 | 168.81M |
| April 12, 2024 | 171.20M |
| April 11, 2024 | 182.05M |
| April 10, 2024 | 164.48M |
| April 09, 2024 | 170.17M |
| April 08, 2024 | 166.55M |
| April 05, 2024 | 180.50M |
| April 04, 2024 | 188.26M |
| April 03, 2024 | 193.94M |
| April 02, 2024 | 191.87M |
| April 01, 2024 | 184.64M |
| March 28, 2024 | 196.61M |
| March 27, 2024 | 190.77M |
| March 26, 2024 | 190.29M |
| March 25, 2024 | 169.85M |
| March 22, 2024 | 165.96M |
| March 21, 2024 | 166.45M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-102.76M
Minimum
Jun 16 2022
220.84M
Maximum
Jun 29 2021
-4.721M
Average
-36.37M
Median
Jan 05 2023
Enterprise Value Benchmarks
| Merrimack Pharmaceuticals Inc (DELISTED) | -20.36M |
| TG Therapeutics Inc | 2.412B |
| Mersana Therapeutics Inc | 127.26M |
| Equillium Inc | 20.24M |
| Monopar Therapeutics Inc | 2.064M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.71M |
| Total Expenses (Quarterly) | 9.869M |
| EPS Diluted (Quarterly) | -0.23 |
| Earnings Yield | -24.38% |